Clinical Study Number | 1301.6 |
---|---|
Study Indication | Lymphoma, Non-Hodgkin |
Product | BI 695500 |
Generic Name | BI 695500 |
Lab Code | |
Clinical Phase | III |
Study Title |
A Phase III, randomized, double-blind, multi-center, multi-national trial to evaluate efficacy and safety of BI 695500 versus rituximab as a first-line immunotherapy treatment in patients with low tumor burden follicular lymphoma |
Study Document | Trial statement 1301.6_DR english Trial synopsis 1301.6_DR english |
Clinical Study Number | 1301.1 |
---|---|
Study Indication | Arthritis, Rheumatoid |
Product | BI 695500 |
Generic Name | BI 695500 |
Lab Code | |
Clinical Phase | I/III |
Study Title |
Efficacy, pharmacokinetics, and safety of BI 695500 versus rituximab in patients with moderately to severely active rheumatoid arthritis: a randomized, double-blind, parallel arm, multiple dose, active comparator trial |
Study Document | Trial statement 1301.1 english Trial synopsis 1301.1_DS english |
Clinical Study Number | 1301.4 |
---|---|
Study Indication | Arthritis, Rheumatoid |
Product | BI 695500 |
Generic Name | BI 695500 |
Lab Code | |
Clinical Phase | III |
Study Title |
Safety and Efficacy of BI 695500 in patients with moderately to severely active rheumatoid arthritis: an open-label extension trial |
Study Document | Trial statement 1301.4 english Trial synopsis 1301.4_DS english |
Clinical Study Number | 1301.5 |
---|---|
Study Indication | Lymphoma, Follicular |
Product | BI 695500 |
Generic Name | BI 695500 |
Lab Code | BI 695500 |
Clinical Phase | I |
Study Title |
A randomized, double-blind, parallel-arm, Phase I study to evaluate pharmacokinetics and pharmacodynamics of BI 695500 vs. rituximab (MabThera®) induction immunotherapy as firstline treatment in patients with low tumor burden follicular lymphoma. |
Study Document | Trial synopsis 1301.5 english |
Clinical Study Number | 1301.2 |
---|---|
Study Indication | Coronary Artery Disease ; Lymphoma, Non-Hodgkin |
Product | BI 695500 |
Generic Name | BI 695500 |
Lab Code | BI 695500 |
Clinical Phase | III |
Study Title |
A randomized, double-blind, multi-center, multi-national Phase III trial to compare efficacy and safety of BI 695500 plus chemotherapy versus rituximab plus chemotherapy in patients with untreated follicular non- Hodgkin’s lymphoma |
Study Document | Trial statement 1301.2 english |
Download our Policy on Transparency and Publication of Clinical Study Data.Download
Browse our clinical study overview and read study synopses and lay summaries.
Learn about our process of responsible sharing of clinical study data and documents and request access to data and documents.